These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 34275020)

  • 1. Design, implementation and initial findings of COVID-19 research in the Rotterdam Study: leveraging existing infrastructure for population-based investigations on an emerging disease.
    Licher S; Terzikhan N; Splinter MJ; Velek P; van Rooij FJA; Heemst JV; Haarman AEG; Thee EF; Geurts S; Mens MMJ; van der Schaft N; de Feijter M; Pardo LM; Kieboom BCT; Ikram MA
    Eur J Epidemiol; 2021 Jun; 36(6):649-654. PubMed ID: 34275020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Objectives, design and main findings until 2020 from the Rotterdam Study.
    Ikram MA; Brusselle G; Ghanbari M; Goedegebure A; Ikram MK; Kavousi M; Kieboom BCT; Klaver CCW; de Knegt RJ; Luik AI; Nijsten TEC; Peeters RP; van Rooij FJA; Stricker BH; Uitterlinden AG; Vernooij MW; Voortman T
    Eur J Epidemiol; 2020 May; 35(5):483-517. PubMed ID: 32367290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rotterdam Study: 2016 objectives and design update.
    Hofman A; Brusselle GG; Darwish Murad S; van Duijn CM; Franco OH; Goedegebure A; Ikram MA; Klaver CC; Nijsten TE; Peeters RP; Stricker BH; Tiemeier HW; Uitterlinden AG; Vernooij MW
    Eur J Epidemiol; 2015 Aug; 30(8):661-708. PubMed ID: 26386597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rotterdam Study: 2018 update on objectives, design and main results.
    Ikram MA; Brusselle GGO; Murad SD; van Duijn CM; Franco OH; Goedegebure A; Klaver CCW; Nijsten TEC; Peeters RP; Stricker BH; Tiemeier H; Uitterlinden AG; Vernooij MW; Hofman A
    Eur J Epidemiol; 2017 Sep; 32(9):807-850. PubMed ID: 29064009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rotterdam Study: 2014 objectives and design update.
    Hofman A; Darwish Murad S; van Duijn CM; Franco OH; Goedegebure A; Ikram MA; Klaver CC; Nijsten TE; Peeters RP; Stricker BH; Tiemeier HW; Uitterlinden AG; Vernooij MW
    Eur J Epidemiol; 2013 Nov; 28(11):889-926. PubMed ID: 24258680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Rotterdam Study: 2012 objectives and design update.
    Hofman A; van Duijn CM; Franco OH; Ikram MA; Janssen HL; Klaver CC; Kuipers EJ; Nijsten TE; Stricker BH; Tiemeier H; Uitterlinden AG; Vernooij MW; Witteman JC
    Eur J Epidemiol; 2011 Aug; 26(8):657-86. PubMed ID: 21877163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort (MaastrICCht).
    Tas J; van Gassel RJJ; Heines SJH; Mulder MMG; Heijnen NFL; Acampo-de Jong MJ; Bels JLM; Bennis FC; Koelmann M; Groven RVM; Donkers MA; van Rosmalen F; Hermans BJM; Meex SJ; Mingels A; Bekers O; Savelkoul P; Oude Lashof AML; Wildberger J; Tijssen FH; Buhre W; Sels JEM; Ghossein-Doha C; Driessen RGH; Kubben PL; Janssen MLF; Nicolaes GAF; Strauch U; Geyik Z; Delnoij TSR; Walraven KHM; Stehouwer CD; Verbunt JAMCF; Van Mook WNKA; van Santen S; Schnabel RM; Aries MJH; van de Poll MCG; Bergmans D; van der Horst ICC; van Kuijk S; van Bussel BCT
    BMJ Open; 2020 Sep; 10(9):e040175. PubMed ID: 32994259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Rotterdam Study: objectives and design update.
    Hofman A; Breteler MM; van Duijn CM; Krestin GP; Pols HA; Stricker BH; Tiemeier H; Uitterlinden AG; Vingerling JR; Witteman JC
    Eur J Epidemiol; 2007; 22(11):819-29. PubMed ID: 17955331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Rotterdam Study: 2010 objectives and design update.
    Hofman A; Breteler MM; van Duijn CM; Janssen HL; Krestin GP; Kuipers EJ; Stricker BH; Tiemeier H; Uitterlinden AG; Vingerling JR; Witteman JC
    Eur J Epidemiol; 2009; 24(9):553-72. PubMed ID: 19728115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case-control study of patient characteristics, knowledge of the COVID-19 disease, risk behaviour and mental state in patients visiting an emergency room with COVID-19 symptoms in the Netherlands.
    van der Valk JPM; Heijboer FWJ; van Middendorp H; Evers AWM; In 't Veen JCCM
    PLoS One; 2021; 16(4):e0249847. PubMed ID: 33909639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
    Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
    Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early public adherence with and support for stay-at-home COVID-19 mitigation strategies despite adverse life impact: a transnational cross-sectional survey study in the United States and Australia.
    Czeisler MÉ; Howard ME; Robbins R; Barger LK; Facer-Childs ER; Rajaratnam SMW; Czeisler CA
    BMC Public Health; 2021 Mar; 21(1):503. PubMed ID: 33722226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifelines COVID-19 cohort: investigating COVID-19 infection and its health and societal impacts in a Dutch population-based cohort.
    Mc Intyre K; Lanting P; Deelen P; Wiersma HH; Vonk JM; Ori APS; Jankipersadsing SA; Warmerdam R; van Blokland I; Boulogne F; Dijkema MXL; Herkert JC; Claringbould A; Bakker O; Lopera Maya EA; Bültmann U; Zhernakova A; Reijneveld SA; Zijlstra E; Swertz MA; Brouwer S; van Ooijen R; Angelini V; Dekker LH; Sijtsma A; Scherjon SA; Wijmenga C; Dekens JAM; Mierau J; Boezen HM; Franke L
    BMJ Open; 2021 Mar; 11(3):e044474. PubMed ID: 33737436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and overview of the Origins of Alzheimer's Disease Across the Life course (ORACLE) study.
    Eur J Epidemiol; ; . PubMed ID: 33324997
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.